a public good project by the
Synthesis
Company
of California

© 2026

Bradley C. Leibovich | doi.page

0 works0 citations0 h-index

Bradley C. Leibovich

Mayo Clinic(US)WinnMed(US)Mayo Clinic in Arizona(US)

Publications by Year

Research Areas

Renal cell carcinoma treatment, Renal and related cancers, Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics

Most-Cited Works

→ Renal Mass and Localized Renal Cancer: AUA Guideline(2017)1,222 cited
→ Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up(2006)867 cited
→ Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma(2003)818 cited
→ Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target(2004)763 cited
→ Every Minute Counts When the Renal Hilum Is Clamped During Partial Nephrectomy(2010)752 cited
→ Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy(2008)714 cited

→ The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus(2004)

688 cited

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.(2003)

→ Nephron Sparing Surgery for Appropriately Selected Renal Cell Carcinoma Between 4 and 7 Cm Results in Outcome Similar to Radical Nephrectomy(2004)582 cited

→ PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma(2007)564 cited